мÓÆÂÁùºÏ²Ê¿ª½±Ö±²¥

Ìý

Dr. Davenport Huyer obtained a B.Eng in Chemical Engineering at Queen’s University (2014), a PhD in Chemical and Biomedical Engineering at the University of Toronto (2019), and completed postdoctoral training at Johns Hopkins University. His interdisciplinary team works at the intersection of immunology, organic chemistry, and degradable polymer design focused on marrying characterization of dysregulated inflammation to new material technologies. Synthetic polymers provide the foundation to diverse medical devices in the clinic yet are fraught with clinical challenges, which motivates the engineering of materials that can better interact with the host environment. His research is focused in (a) phenotyping of patient specific heterogeneity and material specific mechanism of the immune cell driven biomaterial host response, (b) the engineering of new polymer materials that can instruct inflammation for use in degradable medical devices. This research thrives on multidisciplinary thinking, combining clinical motivations with the cutting edge of biomaterial design at interface with mechanistic immunology.